Treatment-free remission in CML patients with additional chromosome abnormalities in the Philadelphia-positive clone or variant Philadelphia translocations.
Simone ClaudianiLynette CheeFiona FernandoLoretta BrownUdayakumar M AchandiraAfzal KhanKate RothwellChloe HaydenIoannis KoutsavlisGuy HannahAndrew J InnesJane F ApperleyDragana MilojkovicPublished in: American journal of hematology (2024)
Probability of treatment-free remission (TFR) in CML patients with additional chromosomal abnormalities (ACA) in the Philadelphia-positive clone or variant Philadelphia translocations (ACA/Var-Ph group, blue panel), in those with no cytogenetic abnormality other than the classical Philadelphia translocation (c-Ph group, green panel) and in the subgroups of CML patients with high-risk ACA (HR-ACA, yellow panel) and Var-Ph (red panel).